Form 4 for FDS FactSet
Accepted 2022-12-22 00:00:00 ET · period of report 2022-12-21 · accession 0001013237-22-000201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-22 | 2022-12-21 | FDS | Reeve Jonathan | EVP, Head of CTS | M - OptEx | $316.71 | +350 | 527.83 | +197% | +$110.8K |
| D | 2022-12-22 | 2022-12-21 | FDS | Reeve Jonathan | EVP, Head of CTS | S - Sale+OE | $403.81 | -350 | 177.83 | -66% | -$141.3K |
| D | 2022-12-22 | 2022-12-21 | FDS | Reeve Jonathan | EVP, Head of CTS | M - OptEx | $0.00 | -350 | 2,591 | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-21 | M | A | 350 | $316.71 | 527.83 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-21 | S | D | 350 | $403.81 | 177.83 | D | — | — | (F1) This transaction was executed in multiple trades with sales prices ranging from $403.77 to $403.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-12-21 | M | D | 350 | $0.00 | 2,591 | D | $316.71 · — to 2030-11-09 | 350 Common Stock | (F2) Options were granted on November 9, 2020 and vest ratably at 20% per year over five years upon the anniversary of the date of grant. |